Tegafur is an anti-cancer prodrug used to treat various cancers, most commonly colorectal cancer and stomach cancer, often in combination with uracil (as the drug Tegafur+Uracil or UFT) and calcium folinate to enhance its effectiveness and reduce side effects. It works by converting to 5-fluorouracil (5-FU), which interferes with the growth of cancer cells by disrupting their DNA and RNA synthesis. It is grouped under the following drug class(es): Cytotoxics. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nitobanil, Exonal, Fulfeel, Lifril and Lamar. Its PubChem CID is 5386.
Tegafur
| CAS No | 17902-23-7 |
|---|---|
| Molecular Formula | C8H9FN2O3 |
| Molecular Weight | 200.17 g/mol |
| Synonyms | 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tegafur is an anti-cancer prodrug used to treat various cancers, most commonly colorectal cancer and stomach cancer, often in combination with uracil (as the drug Tegafur+Uracil or UFT) and calcium folinate to enhance its effectiveness and reduce side effects.
The listed CAS number is 17902-23-7.
The listed molecular formula is C8H9FN2O3.
The listed molecular weight is 200.17 g/mol.
5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione.
The source lists Nitobanil, Exonal, Fulfeel, Lifril and Lamar.